Every few weeks, a brand approaches us with the same idea: “We want to do a NAD+ precursor gummy.” It sounds simple enough. Take a popular ingredient, put it in a gummy, and you’ve got a product that people actually want to take. But here’s the reality most brands don’t see until it’s too late-a NAD+ precursor gummy is a stability problem first and a flavor problem second.
This isn’t about what NAD+ precursors do in the body. It’s about what the gummy does to them. And from a manufacturing perspective, that’s where most products go wrong before they ever reach a consumer.
The Gummy Matrix Is Not a Neutral Delivery System
Gummies are not just candy with an active ingredient stirred in. They are high-moisture, acidified, carbohydrate-dense systems that actively stress sensitive molecules. A typical gummy base sits at a pH between 3.0 and 4.2, with water activity between 0.55 and 0.75, and processing temperatures often above 70°C. That combination is rough on many NAD+ precursor forms.
Here’s what the matrix can do to the active:
- Low pH can trigger acid-catalyzed hydrolysis of sensitive bonds in certain precursor compounds.
- High water activity increases molecular mobility, speeding up degradation reactions.
- Heat exposure during cooking and depositing can degrade heat-sensitive actives before packaging even happens.
- Hygroscopic actives pull moisture from the gummy bulk, creating local zones of high water content that ruin texture and accelerate breakdown.
- High ionic load from active salts interferes with pectin or gelatin gelation, leading to poor set, syneresis, or a rubbery mouthfeel.
At KorNutra, we treat NAD+ precursor gummies as a matrix-compatibility challenge long before anyone talks about flavor profiles or colors.
Not All NAD+ Precursors Are Gummy-Friendly
The specific form of the precursor matters more than most brands realize. Some forms are robust as dry powders but fall apart when dispersed in a warm, acidic, high-moisture slurry. Others are supplied as hygroscopic salts that clump, absorb moisture, or migrate during shelf life.
Here’s the critical part: if your label lists a specific precursor, the finished product must retain that intact ingredient through the entire expiration date. It is not acceptable for the gummy to contain a related degradation product that happens to show up in a non-specific assay. That is a compliance failure, not a minor quality issue.
That’s why we require a stability-indicating method before any pilot production. A stability-indicating method separates the intact precursor from its major degradation products. Without it, accelerated stability data can be dangerously misleading.
Why Assay Methods Matter More Than Usual
In many gummies, a standard HPLC assay for the active works fine. NAD+ precursor gummies are different because the active can degrade into chemically similar compounds. If your method only reads total pyridine content or total niacinamide, it might pass the product even when the labeled precursor has largely disappeared.
Under 21 CFR Part 111, you must have specifications for identity, purity, strength, and composition-and you must verify those specs through the end of shelf life. A non-specific method does not satisfy that requirement. At KorNutra, our rule is simple: no qualified stability-indicating assay, no pilot batch.
The Overage Trap
Overage is common in gummy manufacturing, but it is not a strategy. If a brand needs a 30% overage just to make it to 24 months, that’s a sign the matrix is wrong. Overages also create new problems:
- High active loading can make the gummy bitter, gritty, or poorly textured.
- Excess active salt can shift pH and interfere with gelation.
- Release assay may run too high, risking upper specification failures.
- Overages add cost and reduce formulation flexibility.
The goal should be to design the matrix so the active remains as stable as possible. Overage should be a calculated correction based on real-time and accelerated stability data-not a guess.
A cGMP Formulation Sequence for NAD+ Precursor Gummies
At KorNutra, we follow a disciplined sequence for this category. It looks like this:
1. Pre-Formulation Screening
Before making a single gummy, we screen the active in simplified model systems under different pH, water activity, and heat conditions. This tells us whether the ingredient can survive the gummy process at all.
2. Matrix Design Around the Active
We design the base around the active’s weaknesses. That may mean adjusting the pectin-to-gelatin ratio, using alternative humectants, lowering water activity, or modifying the acidulant system. The tension is real: pectin gels often need low pH to set, but low pH can accelerate degradation. Gelatin allows more pH flexibility but introduces melt and clarity challenges. These trade-offs must be resolved with data.
3. Post-Cook Active Addition
Where possible, we add the active after the cook step at the lowest viable temperature. This reduces heat exposure. But post-cook addition creates new challenges: maintaining homogeneity in a viscous slurry, preventing agglomerates, and controlling microbial risk.
4. Encapsulation Only When Warranted
Encapsulation or spray-dried forms can protect the active from moisture and pH. But encapsulation is not a free pass. If the encapsulant dissolves during processing or storage, you are back to the same stability problem. Encapsulated powders can also introduce grittiness or poor dispersion if particle size is not controlled.
5. Stability-Indicating Method Qualification
Before pilot production, the assay must separate the intact precursor from its degradants. We validate for accuracy, precision, linearity, specificity, and robustness in the finished matrix.
6. Pilot Stability
Accelerated stability is useful, but real-time data is essential. We run both. A gummy that survives 6 months accelerated but fails real-time is still a failure. Bench-top samples are also not enough because production scale has longer hold times, slower cooling, and more shear.
7. Process Validation
We validate homogeneity, in-process pH, Brix, water activity, deposit weight, and temperature. High-potency actives in viscous gummy slurries can settle or agglomerate if not properly dispersed.
8. Packaging Barrier Selection
NAD+ precursor gummies may need high-barrier films, desiccants, or light protection. Packaging is part of the stability system, not an afterthought.
What Brands Should Ask Before Choosing a NAD+ Precursor Gummy
If you are considering a NAD+ precursor gummy, ask your manufacturer these questions:
- What is the pH and water activity of the base?
- How is the active added: pre-cook or post-cook?
- What heat history does the active experience?
- Is the assay stability-indicating for the labeled precursor and its degradants?
- What overage is proposed, and what data justifies it?
- Have pilot stability batches been run on production-scale equipment?
- What packaging barrier is required?
- How is homogeneity verified in the finished gummies?
If a manufacturer cannot answer those questions, the product is not ready for commercial launch.
The KorNutra Perspective
NAD+ precursor gummies can be manufactured well-but only if the development team treats them as a stability challenge from day one. The gummy format is not neutral. It applies heat, moisture, acid, and time to the active. A flavor-first development process will produce a product that tastes great in a sample and fails later on assay.
At KorNutra, our default position is: prove the matrix can hold the molecule before discussing colors, flavors, or marketing. If the chemistry doesn’t survive the gummy, nothing else matters.